Opioid Antagonist in the Treatment of Ischemic Stroke
Open Access
- 18 June 2021
- journal article
- review article
- Published by MDPI AG in Brain Sciences
- Vol. 11 (6), 805
- https://doi.org/10.3390/brainsci11060805
Abstract
Stroke is a leading cause of death and disability, and novel treatments need to be found, particularly drugs with neuroprotective and restorative effects. Lately, there has been an increased interest in the relationship between opioids and ischemic stroke. To further appreciate this association between opioids and stroke, we conducted a systematic review to investigate anti-opioid medication’s effectiveness in treating ischemic stroke. We used PubMed advanced-strategy and Google Scholar searches and only included full-text clinical trials on humans and written in the English language. After applying the inclusion/exclusion criteria, seven clinical trials were reviewed. Only one of the naloxone and nalmefene clinical trials showed statistically favorable results. Overall, the nalmefene clinical trials used more updated measures (NIHSS, GOS) to evaluate recovery and functional status in ischemic stroke patients than the naloxone clinical trials. There was less bias in the nalmefene clinical trials. Animal and in vitro studies have showed promising results. Additional research should be conducted with new clinical trials of both drugs with larger samples in patients less than 70 years old and moderate to severe infarcts.This publication has 22 references indexed in Scilit:
- (+)-Naltrexone is neuroprotective and promotes alternative activation in the mouse hippocampus after cardiac arrest/cardiopulmonary resuscitationBrain, Behavior, and Immunity, 2015
- Nanomolar Naloxone Attenuates Neurotoxicity Induced by Oxidative Stress and Survival Motor Neuron Protein DeficiencyNeurotoxicity Research, 2013
- Association of Intensive Morphine Treatment and Increased Stroke Incidence in Prostate Cancer Patients: A Population-based Nested Case–Control StudyJapanese Journal of Clinical Oncology, 2013
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Cervene (Nalmefene) in Acute Ischemic StrokeStroke, 2000
- A double blind randomized pilot trial of naloxone in the treatment of acute ischemic strokeNeurological Sciences, 1991
- Effect of Naloxone on Acute StrokePharmacopsychiatry, 1988
- A double blind trial of naloxone in the treatment of acute stroke.Stroke, 1984
- Naloxone administration to patients with acute stroke.Stroke, 1984